AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 1 filers reported holding AMAG PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $107,000 | +9.2% | 11,384 | -11.5% | 0.00% | 0.0% |
| Q2 2020 | $98,000 | +34.2% | 12,867 | +8.9% | 0.00% | 0.0% |
| Q1 2020 | $73,000 | -49.3% | 11,813 | 0.0% | 0.00% | -33.3% |
| Q4 2019 | $144,000 | +8.3% | 11,813 | +2.6% | 0.00% | 0.0% |
| Q3 2019 | $133,000 | +17.7% | 11,511 | +2.1% | 0.00% | +50.0% |
| Q2 2019 | $113,000 | -21.5% | 11,271 | +1.1% | 0.00% | -33.3% |
| Q1 2019 | $144,000 | -11.7% | 11,148 | +3.9% | 0.00% | -25.0% |
| Q4 2018 | $163,000 | -20.1% | 10,725 | +5.0% | 0.00% | 0.0% |
| Q3 2018 | $204,000 | +5.7% | 10,214 | +3.0% | 0.00% | 0.0% |
| Q2 2018 | $193,000 | +1.0% | 9,913 | +4.8% | 0.00% | 0.0% |
| Q1 2018 | $191,000 | +56.6% | 9,457 | +2.8% | 0.00% | +33.3% |
| Q4 2017 | $122,000 | -26.1% | 9,200 | +2.9% | 0.00% | -25.0% |
| Q3 2017 | $165,000 | +3.8% | 8,937 | +3.4% | 0.00% | 0.0% |
| Q2 2017 | $159,000 | -12.2% | 8,642 | +7.6% | 0.00% | -20.0% |
| Q1 2017 | $181,000 | -30.4% | 8,030 | +7.4% | 0.01% | -28.6% |
| Q4 2016 | $260,000 | +51.2% | 7,476 | +6.3% | 0.01% | +40.0% |
| Q3 2016 | $172,000 | +6.2% | 7,031 | +4.0% | 0.01% | 0.0% |
| Q2 2016 | $162,000 | +11.7% | 6,760 | +9.4% | 0.01% | +25.0% |
| Q1 2016 | $145,000 | – | 6,177 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $14 | 0.00% |